Skip to main content
Erschienen in: Pathology & Oncology Research 2/2013

01.04.2013 | Research

Melanoma Screening in a Hungarian Nuclear Power Plant

verfasst von: Veronika Tóth, Beáta Somlai, Zsófia Hatvani, József Szakonyi, István Gaudi, Sarolta Kárpáti

Erschienen in: Pathology & Oncology Research | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

The industrial use of the ionizing radiation (IR) particularly stresses the safe work, regular health control is inevitable. Since previous occupational cohorts reported contradictory data on the incidence of melanoma among nuclear industry workers, and in few publications significant increase of it has been described, our clinic was requested by the industry to screen malignant skin tumours among the workers of a power plant. Within a year we have investigated 556 workers, 275 females and 281 males. Out of them 283, majorly males had been officially confirmed as to be employed at hazardous, but strictly controlled environment for an average of 18 years (1–32 years). To distinguish between IR and environmental UV (UVA+UVB) induced cutaneous malignancies we determined the sun and tanning bed exposure of the workers. One in situ melanoma developed in a woman with type I skin, bullous sunburns in the history, who had worked in safe environment for 26 years. Basal cell carcinoma was identified in two men, each of them worked for more than 20 years with IR (in hazardous environment). One had type I skin, the other had type II skin. These results didn’t differ significantly (chi-squared test; p = 0, 2437 and 1, 0) from the national population data and the results of Euromelanoma screening campaign in Hungary. Our data clearly show, that 1./UV exposure and skin type should be evaluated in occupation cohort studies. 2./The melanoma incidence was not significantly higher among the employees of the power plant than in the general Hungarian population, according to the results of our study, the only Hungarian power plant is safe as far as the skin carcinogenesis is concerned.
Literatur
1.
Zurück zum Zitat Austin DF, Reynolds PJ, Snyder MA, Biggs MW, Stubbs HA (1981) Malignant melanoma among employees of Lawrence Livermore National Laboratory. Lancet 2:712–716PubMedCrossRef Austin DF, Reynolds PJ, Snyder MA, Biggs MW, Stubbs HA (1981) Malignant melanoma among employees of Lawrence Livermore National Laboratory. Lancet 2:712–716PubMedCrossRef
2.
Zurück zum Zitat Acquavella JF, Wilkinson GS, Tietjen GL, Key CR, Voelz GL (1982) Malignant melanoma incidence at the Los Alamos National Laboratory. Lancet 319:883–884CrossRef Acquavella JF, Wilkinson GS, Tietjen GL, Key CR, Voelz GL (1982) Malignant melanoma incidence at the Los Alamos National Laboratory. Lancet 319:883–884CrossRef
3.
Zurück zum Zitat Acquavella JF, Wilkinson GS, Tietjen GL, Key CR, Stebbings JH, Voelz GL (1983) A melanoma case–control study at the Los Alamos National Laboratory. Health Phys 45:587–592PubMedCrossRef Acquavella JF, Wilkinson GS, Tietjen GL, Key CR, Stebbings JH, Voelz GL (1983) A melanoma case–control study at the Los Alamos National Laboratory. Health Phys 45:587–592PubMedCrossRef
4.
Zurück zum Zitat Johnson CJ (1984) Cancer incidence in an area of radioactive fallout downwind from the Nevada Test Site. JAMA 251:230–236PubMedCrossRef Johnson CJ (1984) Cancer incidence in an area of radioactive fallout downwind from the Nevada Test Site. JAMA 251:230–236PubMedCrossRef
5.
Zurück zum Zitat Smith PG, Douglas AJ (1986) Mortality of workers at the Sellafield plant of British Nuclear Fuels. Br Med J 293:845–854CrossRef Smith PG, Douglas AJ (1986) Mortality of workers at the Sellafield plant of British Nuclear Fuels. Br Med J 293:845–854CrossRef
6.
Zurück zum Zitat Kendall GM, Muirhead CR, MacGibbon BH, O’Hagan JA, Conquest AJ, Goodill AA et al (1992) Mortality and occupational exposure to radiation: first analysis of the National Registry for Radiation Workers. Br Med J 304:220–225CrossRef Kendall GM, Muirhead CR, MacGibbon BH, O’Hagan JA, Conquest AJ, Goodill AA et al (1992) Mortality and occupational exposure to radiation: first analysis of the National Registry for Radiation Workers. Br Med J 304:220–225CrossRef
7.
Zurück zum Zitat Carpenter L, Higgins C, Douglas A, Fraser C, Beral V, Smith P (1994) Combined analysis of mortality in three United Kingdom nuclear industry workforces, 1946–1988. Radiat Res 138:224–238PubMedCrossRef Carpenter L, Higgins C, Douglas A, Fraser C, Beral V, Smith P (1994) Combined analysis of mortality in three United Kingdom nuclear industry workforces, 1946–1988. Radiat Res 138:224–238PubMedCrossRef
8.
Zurück zum Zitat Austin DF, Reynolds P (1997) Investigation of an excess of melanoma among employees of the Lawrence Livermore National Laboratory. Am J Epidemiol 145:524–531PubMedCrossRef Austin DF, Reynolds P (1997) Investigation of an excess of melanoma among employees of the Lawrence Livermore National Laboratory. Am J Epidemiol 145:524–531PubMedCrossRef
9.
Zurück zum Zitat Moore DH 2nd, Patterson HW, Hatch F, Discher D, Schneider JS, Bennett D et al (1997) Case–controll study of malignant melanoma among employees of the Lawrence Livermore National Laboratory. Am J Ind Med 32:377–391PubMedCrossRef Moore DH 2nd, Patterson HW, Hatch F, Discher D, Schneider JS, Bennett D et al (1997) Case–controll study of malignant melanoma among employees of the Lawrence Livermore National Laboratory. Am J Ind Med 32:377–391PubMedCrossRef
10.
Zurück zum Zitat Sont WN, Zielinski JM, Ashmore JE, Jiang H, Krewski D, Fair ME et al (2001) First analysis of cancer incidence and occupational radiation exposure based on the National Dose Registry of Canada. Am J Epidemiol 153:309–318PubMedCrossRef Sont WN, Zielinski JM, Ashmore JE, Jiang H, Krewski D, Fair ME et al (2001) First analysis of cancer incidence and occupational radiation exposure based on the National Dose Registry of Canada. Am J Epidemiol 153:309–318PubMedCrossRef
11.
Zurück zum Zitat Whorton MD, Moore ND, Seward JP, Noonan KA, Mendelsohn ML (2004) Cancer incidence rates among Lawrence Livermore National Laboratory (LLNL) employees: 1974–1997. Am J Ind Med 45:24–33PubMedCrossRef Whorton MD, Moore ND, Seward JP, Noonan KA, Mendelsohn ML (2004) Cancer incidence rates among Lawrence Livermore National Laboratory (LLNL) employees: 1974–1997. Am J Ind Med 45:24–33PubMedCrossRef
12.
Zurück zum Zitat Zielinski JM, Gamer MJ, Krewski D, Ashmore JP, Band PR, Fair ME et al (2005) Decreases in occupational exposure to ionizing radiation among Canadian dental workers. J Can Dent Assoc 71:29–33PubMed Zielinski JM, Gamer MJ, Krewski D, Ashmore JP, Band PR, Fair ME et al (2005) Decreases in occupational exposure to ionizing radiation among Canadian dental workers. J Can Dent Assoc 71:29–33PubMed
13.
Zurück zum Zitat Telle-Lamberton M, Samson E, Caër S, Bergot D, Bard D, Bermann F et al (2007) External radiation exposure and mortality in a cohort of French nuclear workers. Occup Environ Med 64:694–700PubMedCrossRef Telle-Lamberton M, Samson E, Caër S, Bergot D, Bard D, Bermann F et al (2007) External radiation exposure and mortality in a cohort of French nuclear workers. Occup Environ Med 64:694–700PubMedCrossRef
14.
Zurück zum Zitat Cardis E, Vrijheid M, Blettner M, Gilbert E, Hakama M, Hill C et al (2007) The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks. Radiat Res 167:396–416PubMedCrossRef Cardis E, Vrijheid M, Blettner M, Gilbert E, Hakama M, Hill C et al (2007) The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks. Radiat Res 167:396–416PubMedCrossRef
15.
Zurück zum Zitat Gun RT, Parson J, Crouch P, Ryan P, Hiller JE (2008) Mortality and cancer incidence of Australian participants in the British nuclear tests in Australia. Occup Environ Med 65:843–848PubMedCrossRef Gun RT, Parson J, Crouch P, Ryan P, Hiller JE (2008) Mortality and cancer incidence of Australian participants in the British nuclear tests in Australia. Occup Environ Med 65:843–848PubMedCrossRef
16.
Zurück zum Zitat Jacob P, Rühm W, Walsh L, Blettner M, Hammer G, Zeeb H (2009) Cancer risk of radiation workers larger than expected? Occup Environ Med 66:789–796PubMedCrossRef Jacob P, Rühm W, Walsh L, Blettner M, Hammer G, Zeeb H (2009) Cancer risk of radiation workers larger than expected? Occup Environ Med 66:789–796PubMedCrossRef
17.
Zurück zum Zitat Lens MB, Dawes M (2004) Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 150:179–185PubMedCrossRef Lens MB, Dawes M (2004) Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 150:179–185PubMedCrossRef
18.
Zurück zum Zitat Garbe C, McLeod GR, Buettner PG (2000) Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer 89:1269–1278PubMedCrossRef Garbe C, McLeod GR, Buettner PG (2000) Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer 89:1269–1278PubMedCrossRef
19.
Zurück zum Zitat Turai I, Souskevich G (2001) The radiological accident in Lilo, Gerogia. Official joint report of the IAEA and the WHO. International Atomic Energy Agency, Vienna Turai I, Souskevich G (2001) The radiological accident in Lilo, Gerogia. Official joint report of the IAEA and the WHO. International Atomic Energy Agency, Vienna
20.
Zurück zum Zitat Link EM, Flanagan K, Michalowski AS, Blower PJ (1999) Low-doses of ionising radiation induce melanoma metastases and trigger the immune system—adrenal axis feedback loop. Eur J Cancer 35:1526–1533PubMedCrossRef Link EM, Flanagan K, Michalowski AS, Blower PJ (1999) Low-doses of ionising radiation induce melanoma metastases and trigger the immune system—adrenal axis feedback loop. Eur J Cancer 35:1526–1533PubMedCrossRef
21.
Zurück zum Zitat Charles MW (2007) Radon exposure of the skin: I. Biological effects J Radiol Prot 27:231–252CrossRef Charles MW (2007) Radon exposure of the skin: I. Biological effects J Radiol Prot 27:231–252CrossRef
22.
Zurück zum Zitat Lei U, Masmas TN, Frentz G (2001) Occupational non-melanoma skin cancer. Acta Derm Venerol 81:415–417PubMedCrossRef Lei U, Masmas TN, Frentz G (2001) Occupational non-melanoma skin cancer. Acta Derm Venerol 81:415–417PubMedCrossRef
23.
Zurück zum Zitat Gawkrodger DJ (2004) Occupational skin cancers. Occup Med 54:458–463CrossRef Gawkrodger DJ (2004) Occupational skin cancers. Occup Med 54:458–463CrossRef
24.
Zurück zum Zitat Gaudi I, Kásler M (2003) New cases of melanoma as documented in the National Cancer Registry. Hungarian Oncology 47:13–17PubMed Gaudi I, Kásler M (2003) New cases of melanoma as documented in the National Cancer Registry. Hungarian Oncology 47:13–17PubMed
Metadaten
Titel
Melanoma Screening in a Hungarian Nuclear Power Plant
verfasst von
Veronika Tóth
Beáta Somlai
Zsófia Hatvani
József Szakonyi
István Gaudi
Sarolta Kárpáti
Publikationsdatum
01.04.2013
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 2/2013
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-012-9587-8

Weitere Artikel der Ausgabe 2/2013

Pathology & Oncology Research 2/2013 Zur Ausgabe

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.